W. Meesmann

715 total citations
47 papers, 387 citations indexed

About

W. Meesmann is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, W. Meesmann has authored 47 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pathology and Forensic Medicine. Recurrent topics in W. Meesmann's work include Cardiac Imaging and Diagnostics (11 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Arrhythmias and Treatments (5 papers). W. Meesmann is often cited by papers focused on Cardiac Imaging and Diagnostics (11 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Arrhythmias and Treatments (5 papers). W. Meesmann collaborates with scholars based in Germany. W. Meesmann's co-authors include V. Wiegand, H Gülker, Patricia Bucher, Mirjam Keßler, Gunnar Schley, B Krämer, M. Neumann, Benjamin Krämer, Claus Martin and F Bender and has published in prestigious journals such as Cardiovascular Research, Pflügers Archiv - European Journal of Physiology and Journal of Molecular Medicine.

In The Last Decade

W. Meesmann

44 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Meesmann Germany 10 274 83 80 74 45 47 387
Åke C. Hjalmarson Sweden 7 228 0.8× 48 0.6× 79 1.0× 83 1.1× 33 0.7× 9 311
W. Braasch United States 7 230 0.8× 98 1.2× 105 1.3× 83 1.1× 25 0.6× 15 372
Gordon H. Templeton United States 12 228 0.8× 123 1.5× 93 1.2× 81 1.1× 41 0.9× 17 433
R Shuchleib United States 6 261 1.0× 94 1.1× 162 2.0× 75 1.0× 51 1.1× 7 384
Kevin C. Preuss United States 10 183 0.7× 87 1.0× 87 1.1× 69 0.9× 73 1.6× 16 317
JOHN J. SAŸEN United States 9 260 0.9× 127 1.5× 71 0.9× 30 0.4× 44 1.0× 15 383
George J. Peirce United States 9 212 0.8× 116 1.4× 60 0.8× 30 0.4× 29 0.6× 15 356
C Friedland Mexico 4 288 1.1× 48 0.6× 105 1.3× 75 1.0× 44 1.0× 12 426
ML Weisfeldt United States 8 293 1.1× 82 1.0× 24 0.3× 44 0.6× 44 1.0× 12 376
F. Kosche Germany 6 200 0.7× 121 1.5× 40 0.5× 31 0.4× 15 0.3× 13 287

Countries citing papers authored by W. Meesmann

Since Specialization
Citations

This map shows the geographic impact of W. Meesmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Meesmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Meesmann more than expected).

Fields of papers citing papers by W. Meesmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Meesmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Meesmann. The network helps show where W. Meesmann may publish in the future.

Co-authorship network of co-authors of W. Meesmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Meesmann. A scholar is included among the top collaborators of W. Meesmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Meesmann. W. Meesmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martin, Claus, et al.. (1988). Prophylactic Lidocaine. Journal of Cardiovascular Pharmacology. 12(5). 571–578. 3 indexed citations
3.
Martin, Claus & W. Meesmann. (1985). Antiarrhythmic Effect of Regional Myocardial Chemical Sympathectomy in the Early Phase of Coronary Artery Occlusion in Dogs. Journal of Cardiovascular Pharmacology. 7. S76–S80. 7 indexed citations
4.
Meesmann, W., et al.. (1977). [Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(7). 341–50. 7 indexed citations
5.
Gülker, H, et al.. (1977). Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release. Basic Research in Cardiology. 72(5). 547–562. 26 indexed citations
7.
Meesmann, W., et al.. (1976). [Prevention of arrhythmias in acute myocardial infarct using the beta-sympatholytic ICI 66082].. PubMed. 82 Pt 2. 1102–5. 2 indexed citations
8.
Meesmann, W., et al.. (1976). [Acute myocardial infarct and pindolol. Effect of a beta sympatholytic with intrinsic sympathomimetic activity on hemodynamics and contractility].. PubMed. 26(8). 1561–5. 1 indexed citations
9.
Meesmann, W., et al.. (1975). [Effect of spontaneous collateral and assisted circulation in the extent of ischemia in ECG following experimental coronary occlusion].. PubMed. 26(27-28). 1310–2. 1 indexed citations
10.
Schley, Gunnar, et al.. (1975). [Influence of spontaneous collaterals on the fibrillation threshold of the heart following acute coronary occlusion].. PubMed. 64(3). 202–11. 3 indexed citations
11.
Schley, Gunnar, et al.. (1973). [Effect of the magnitude of infarction and of spontaneous collaterals on the fibrillation threshold of the heart in acute experimental coronary occlusion].. PubMed. 39. 203–7. 2 indexed citations
12.
Meesmann, W., et al.. (1973). [Characteristics of arrhythmia phases after experimental coronary occlusion].. PubMed. 39. 208–11. 1 indexed citations
13.
Meesmann, W., et al.. (1972). [Plasma enzyme activities and morphology of the myocardium following acute experimental coronary occlusion in relation to the spontanous collateral vessels of the heart].. PubMed. 61(1). 1–10. 1 indexed citations
14.
Meesmann, W., et al.. (1972). [The effect of spontaneous collaterals on acute experimental myocardial infarct].. PubMed. 23(40). 1375–6. 2 indexed citations
15.
Meesmann, W., et al.. (1971). [Nitrite therapy of stenocardia].. PubMed. 96(36). 1444–9. 1 indexed citations
16.
Meesmann, W., et al.. (1970). [Survival rate after acute experimental coronary occlusion as related to the spontaneous collateral vessels in hearts].. PubMed. 153(3). 246–64. 8 indexed citations
17.
Meesmann, W., et al.. (1970). überlebensquote nach akutem experimentellem Coronarverschluß in Abhängigkeit von Spontankollateralen des Herzens. Research in Experimental Medicine. 153(3). 246–264. 22 indexed citations
18.
Braasch, W., et al.. (1960). Beeinflussung der Spontaninsuffizienz des Herz-Lungen-Pr�parates durch Milz- und Lebervenenblut. Pflügers Archiv - European Journal of Physiology. 271(1). 1–13. 1 indexed citations
19.
Meesmann, W., et al.. (1956). Auswirkungen einer elektrischen Milznervenreizung auf die Coronardurchblutung. Pflügers Archiv - European Journal of Physiology. 263(3). 293–303. 10 indexed citations
20.
Meesmann, W., et al.. (1955). Durchblutungs�nderungen im Einstromgebiet der Leber bei hypox�mischen Myokardinsuffizienzen. Pflügers Archiv - European Journal of Physiology. 261(6). 495–506. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026